Cargando…

Supporting Huntington’s Disease Families Through the Ups and Downs of Clinical Trials

Recent years have been turbulent ones for the Huntington’s disease (HD) community. Three clinical trials for HD, including the first Phase 3 trial of a potentially disease modifying genetic therapy for HD, were all brought to a halt in March of 2021. 2022 brought more study roadblocks and an additio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrew, Kelly M., Fox, Leora M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200140/ https://www.ncbi.nlm.nih.gov/pubmed/37038822 http://dx.doi.org/10.3233/JHD-230565

Ejemplares similares

Raising Awareness of Therapeutic Misconception and Optimism Around Clinical Trials in Huntington’s Disease
por: de Bot, Susanne Tamara
Publicado: (2019)

Rectifying rectifier channels in Huntington disease
por: Proft, Juliane, et al.
Publicado: (2014)

Huntington’s disease skeletal muscle has altered T-tubules
por: Khan, Muhammad S., et al.
Publicado: (2021)

Synaptopathy, circuitopathy and the computational biology of Huntington’s disease
por: Hannan, Anthony J.
Publicado: (2018)

Phenotypic Variability in Huntington's Disease
por: Chouksey, Anjali, et al.
Publicado: (2020)

Implications of the Orb2 Amyloid Structure in Huntington’s Disease
por: Hervás, Rubén, et al.
Publicado: (2020)

Evolving mantle convection from bottom up to top down
por: Mitchell, Ross N., et al.
Publicado: (2022)

Commentary: Up, down, right, left: Addressing the shortage of donor lungs for transplantation
por: Wakeam, Elliot, et al.
Publicado: (2020)

A shared mechanism of muscle wasting in cancer and Huntington’s disease
por: Mielcarek, Michal, et al.
Publicado: (2015)

ULK1 cycling: The ups and downs of the autophagy response
por: Zhao, Yan G., et al.
Publicado: (2016)

Compensation in the course of Huntington's disease — More than just a hypothesis?
por: Schiefer, Johannes
Publicado: (2015)

Neural Compensation in Huntington's Disease: Teaching Mental Disorders New Tricks?
por: Wolf, Robert Christian, et al.
Publicado: (2015)

Trojan triplets: RNA-based pathomechanisms for muscle dysfunction in Huntington’s disease
por: Skov, Martin, et al.
Publicado: (2017)

Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date
por: Squitieri, Ferdinando, et al.
Publicado: (2015)

What Goes Up Must Come Down: The Emerging Spectrum of Inhibitory Receptors
por: Yokoyama, Wayne M.
Publicado: (1997)

Manipulating cell motility by Legionella: Speeding up or slowing down?
por: Xu, You, et al.
Publicado: (2023)

Retinal disease: How to use proteomics to speed up diagnosis and metabolomics to slow down degeneration
por: Hurley, James B., et al.
Publicado: (2020)

Resurrection of sildenafil: potential for Huntington’s Disease, too?
por: Achenbach, Jannis, et al.
Publicado: (2022)

Skeletal Muscle Modulates Huntington’s Disease Pathogenesis in Mice: Role of Physical Exercise
por: Corrochano, Silvia, et al.
Publicado: (2018)

Advocacy Recruiting for Huntington’s Disease Clinical Trials
por: Goodman, LaVonne, et al.
Publicado: (2011)

Commentary: London Bridge is falling down—how will we build it up?
por: James, Les, et al.
Publicado: (2021)

Up and down waves of glycemic control and lower-extremity amputation in diabetes
por: Caruso, Paola, et al.
Publicado: (2021)

Activities supporting the growth of Clinical Trial Networks in Australia
por: Nemeh, Fiona, et al.
Publicado: (2022)

Conclusions of the SIGNAL study in Huntington and implications for treatment of other slowly progressive neurodegenerative diseases
por: Zauderer, Maurice, et al.
Publicado: (2023)

Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience
por: Trama, Annalisa, et al.
Publicado: (2020)

Epidemiological and clinical aspects of autoimmune thyroid diseases in children with Down’s syndrome
por: Aversa, Tommaso, et al.
Publicado: (2018)

Clinical trial data in support of changing guidelines in osteoarthritis treatment
por: Balmaceda, Casilda M
Publicado: (2014)

Social support experiences when growing up with a parent with Huntington’s disease
por: Kjoelaas, Siri, et al.
Publicado: (2022)

Bottom-up versus top-down megafauna–vegetation interactions in ancient Beringia
por: Williams, John W.
Publicado: (2022)

Commentary: The molecular pandemonium of coronavirus disease 2019
por: Balsam, Leora B., et al.
Publicado: (2021)

Heart disease and stroke: Down, but not out
por: Kottke, Thomas E., et al.
Publicado: (2021)

From the “top-down” and the “bottom-up”: Centering Foucault’s notion of biopower and individual accountability within systemic racism
por: Zaidi, Zareen, et al.
Publicado: (2021)

Huntington’s Disease Outpatient Clinic for Functional Diagnosis and Treatment: Coming to Consensus: How Long Term Care Facility Procedures Complement Specialist Diagnosis and Treatment
por: Veenhuizen, Ruth, et al.
Publicado: (2018)

Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington’s and Parkinson’s disease
por: Barschke, Peggy, et al.
Publicado: (2022)

Assessing loss to follow-up in the MObile Technology for Improved Family Planning (MOTIF) randomised controlled trial
por: Smith, Chris, et al.
Publicado: (2017)

Motor–Language Coupling in Huntington’s Disease Families
por: Kargieman, Lucila, et al.
Publicado: (2014)

Chorea me a river: depression in Huntington’s disease as an exemplar of precision medicine
por: Hannan, Anthony J
Publicado: (2022)

Seven-year clinical follow-up of premanifest carriers of Huntington's disease
por: Hart, Ellen, et al.
Publicado: (2011)

Huntington’s Disease Clinical Trials Corner: August 2023
por: Estevez-Fraga, Carlos, et al.
Publicado: (2023)

Huntington’s Disease Clinical Trials Corner: February 2018
por: Rodrigues, Filipe B., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6asd1p5qjtl4nd29fkd34otmi0